Article Text

Download PDFPDF
Variant Creutzfeldt–Jakob disease occurring in mother and son
  1. Mario Riverol1,
  2. Jose-Alberto Palma1,
  3. Mónica Alañá2,
  4. Carmen Guerrero-Márquez3,
  5. María Rosario Luquin1,
  6. Alberto Rábano4
  1. 1Department of Neurology and Neurosurgery, University Clinic of Navarra, School of Medicine, Pamplona, Spain
  2. 2Department of Neurology, Salamanca University Hospital, Salamanca, Spain
  3. 3Unidad de Anatomía Patológica, Hospital Universitario Fundación Alcorcón, Madrid, Spain
  4. 4Department of Neuropathology and Tissue Bank, Unidad de Investigación Proyecto Alzheimer, Fundación CIEN, Instituto de Salud Carlos III, Madrid, Spain
  1. Correspondence to Dr Mario Riverol, Department of Neurology and Neurosurgery, University Clinic of Navarra, School of Medicine, Pio XII 36, Pamplona 31008, Spain; mriverol{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


Variant Creutzfeldt–Jakob disease (vCJD) is distinguished from sporadic CJD by a number of characteristics, including a causal association with bovine spongiform encephalopathy (BSE) prions mainly through ingestion, lower sensitivity for 14-3-3 protein in cerebrospinal fluid (CSF), absence of triphasic periodic EEG and death at younger age (mean 28 years vs 65 years).1 Although millions of people have been potentially exposed to the infection, the number of recorded cases of vCJD to date has been small (∼200). One explanation for the low number of cases is that, apart from the homozygosity for methionine at codon 129 of the prion protein gene (PRNP), additional genetic factors might influence the susceptibility to infection.2 3 If there are genetic factors that increase the risk of vCJD, we might expect that the infection would occur in multiple members of certain families with similar exposures. To date, this has not been reported. We describe here a mother and son, in a high-risk BSE region, who developed vCJD.

Case reports

A 41-year-old Spanish man with no history of blood transfusion or tissue transplantation first reported recurrent episodes of amaurosis and diplopia. Subsequently, behavioural alterations and language impairment were noted, and severe cognitive and mood dysfunction rapidly followed. Six months later, he was admitted to the hospital with confabulation, ataxia, dysarthria, acalculia, agraphia, apraxia and upper limb dysmetria. Brain MRI showed symmetrical hyperintensity of …

View Full Text


  • Competing interests None.

  • Patient consent Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.